Catalyst

Slingshot members are tracking this event:

Flamel Technologies(FLML) plans to begin pivotal trials for LiquiTime Ibuprofen in the second half of 2015

Source Link:
http://seekingalpha.com/article/3387765-flamel-technologies-flml-ceo-mike-anderson-on-q2-2015-results-earnings-call-transcript?page=3

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
FLML
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details LiquiTime is Flamel's platform technology for extended-release liquids.
http://seekingalpha....
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Aug 05, 2015
Occurred Source:
http://www.marketwired.com/press-release/flamel-technologies-provides-update-on-corporate-progress-nasdaq-flml-2086556.htm
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Liquitime Ibuprofen
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.